BioAtla, Inc. (BCAB) Misses Q2 EPS by 6c

BioAtla, Inc. (NASDAQ: BCAB) reported Q2 EPS of ($0.32), $0.06 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Befesa SA (BFSA:GR) PT Lowered to EUR35 at Deutsche Bank
• HSBC Downgrades Stellantis NV (STLA:IM) (STLA) to Reduce